Peter Feng Wang

Cost-effectiveness Analysis of Apixaban against Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation in Japan

Isao Kamae, Yoichiro Hashimoto, Yukihiro Koretsune et al. · Clinical Therapeutics · 2015 · 32 citations · Full text

Thrombosis, Venous Thrombosis, Cost-effectiveness Analysis +12

Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database study

Peter Feng Wang, Christopher Yee, Boris Gorsh et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2022 · 31 citations · Full text

Resource utilization and costs of blood management services associated with knee and hip surgeries in US hospitals

Christopher M. Blanchette, Peter Feng Wang, Ashish V. Joshi et al. · Advances in Therapy · 2006 · 21 citations

Healthcare Value, Resource Utilization, Patient Safety +10

Survival outcomes for patients with multiple myeloma in France: A retrospective cohort study using the Système National des Données de Santé national healthcare database

Xavier Leleu, Boris Gorsh, Antoine Bessou et al. · European Journal Of Haematology · 2023 · 11 citations · Full text

Trends in the prevalence of thrombocytopenia among individuals iInfected with hepatitis C Virus in the United States, 1999-2008

Teresa L. Kauf, David R. Nelson, Jonathan Schelfhout et al. · BMC Research Notes · 2012 · 10 citations · Full text